Quantcast

DrugRisk Update: Court to Decide Fate of Mirena Lawsuits Next Month

February 20, 2013

The DrugRisk Resource Center is the Web´s largest source for information on prescription drug research, side effects and legal news. Visit http://www.DrugRisk.com

New York, NY (PRWEB) February 20, 2013

The birth control resource center at DrugRisk.com is alerting women using the IUD contraceptive Mirena of updated legal news added to the site showing a federal court will meet next month to decide the fate of the growing Mirena litigation.

“DrugRisk´s mission is to improve patient safety by providing the latest drug warnings,recalls, studies and legal news. This allows users to have informed discussions with their doctors about drug side effects and decide if they need legal advice,” explains DrugRisk representative Ryan Mayer.

DrugRisk has added information from the FDA showing more than 47,000 patients have filed AERS reports after suffering complications from the Mirena IUD.* Of these, 5079 involved dislocation and 1421 involved migration of the devices, which can perforate or damage the uterine wall.* In more than 6% of cases, patients required hospitalization or surgery.

The resource center has also learned that the FDA warned Bayer, the maker of Mirena, about the marketing of the device in 2009, after they failed to disclose safety risks while claiming the devices could help busy moms with intimacy and make them “look and feel great.”**

DrugRisk reported that, with litigation over Mirena perforation growing, plaintiffs filed a request that cases be consolidated to a special federal Multi-District Litigation court in Ohio.*** The petition estimates that, with more than 2 million users, hundreds of Mirena perforation cases could be filed.

Now, DrugRisk has added legal news that the Joint Panel on Multi-District Litigation will conduct a hearing on March 21, 2013 in order to decide whether cases will be consolidated to one court, and where that will be.****

Anyone affected by a Mirena device is urged to learn about their legal rights to file a claim. Due to the specialized nature of federal MDL drug injury cases, the Drug Risk Resource Center only recommends lawyers who are already handling Mirena lawsuits.

For more information on the research, side effects and litigation news related to Mirena and other medical devices, or to speak with a lawyer, visit http://www.DrugRisk.com.

*FDA AERS Reports for Mirena through June 30, 2012 – drugcite.com/?q=mirena

**NDA 21-225, Mirena (levonorgestrel-releasing intrauterine system) MACMIS # 18166, 12/30/09

***In Re: Mirena IUD Product Liability Litigation, Case No. 1:12-CV-2780; harrismartin.com/media/uploads/documents/DRU-1301-27.pdf

****http://www.jpml.uscourts.gov/sites/jpml/files/Hearing%20Order-3-21-13.pdf

For the original version on PRWeb visit: http://www.prweb.com/releases/prwebmirena-perforation/lawsuit-warnings/prweb10447096.htm


Source: prweb



comments powered by Disqus